The key role of the suprachiasmatic nucleus in the diurnal regulation of anterior pituitary hormone secretions, including PRL, is well established. However, the pathway via suprachiasmatic signals reach the pituitary is ill defined. To determine whether suprachiasmatic efferents innervate neuroendocrine cells, the anterograde tracer, Phaseolus vulgaris leukoagglutinin, was injected iontophoretically into the suprachiasmatic nucleus in parallel with ip administration of fluorogold (20 mg/BW in saline). After visualization of anterogradely labeled processes with a dark blue chromogen, Vibratome sections were immunostained for fluorogold. As fluorogold labeling resulted in dense immunopositive granules without diffuse cytoplasmic labeling, selected sections were further immunostained for cytoplasmic tyrosine hydroxylase (dopamine). Anterogradely labeled suprachiasmatic efferents were observed in the medial preoptic area, periventricular regions, and the lateral aspects of the arcuate and ventromedial nuclei of the hypothalamus, whereas the median eminence and organum vasculosum laminae terminalis lacked labeled suprachiasmatic projections. All of the aforementioned regions contained a high number of cells immunoreactive for fluorogold. However, immunolabeling for fluorogold revealed no retrogradely labeled (ergo neuroendocrine) cells in the suprachiasmatic nucleus. Retrogradely labeled cells in all of these hypothalamic sites, with the exception of the median eminence and organum vasculosum laminae terminalis, were targets of suprachiasmatic nucleus axon terminals. In the preoptic area, anterior hypothalamus, periventricular area, and arcuate nucleus, subpopulations of dopamine cells were retrogradely labeled. In all of these areas, both retrogradely labeled and nonlabeled dopamine cells were frequently found to be in contact with dark blue, anterogradely labeled suprachiasmatic efferents. Electron microscopic examination confirmed the putative connections to be synaptic.
(ergo neuroendocrine) cells in the suprachiasmatic nucleus. Retrogradely labeled cells in all of these hypothalamic sites, with the exception of the median eminence and organum vasculosum laminae terminalis, were targets of suprachiasmatic nucleus axon terminals. In the preoptic area, anterior hypothalamus, periventricular area, and arcuate nucleus, subpopulations of dopamine cells were retrogradely labeled. In all of these areas, both retrogradely labeled and nonlabeled dopamine cells were frequently found to be in contact with dark blue, anterogradely labeled suprachiasmatic efferents. Electron microscopic examination confirmed the putative connections to be synaptic.
This experiment provided evidence that the circadian pacemaker suprachiasmatic nucleus sends efferents onto neuroendocrine cells, but has no contacts with fenestrated capillaries. It was found that a population of median eminence-projective cells targeted by suprachiasmatic axons in the hypothalamus contains dopamine. These observations indicate no direct effect of the circadian pacemaker on the anterior hypophysis, but offer an indirect pathway via circadian signals, mediated by hypothalamic neural systems, that may regulate pituitary hormone secretion, in particular PRL. (Endocrinology 138: 1312-1320, 1997) C IRCADIAN activities are essential for an organism's adaptation to its environment. For example, timed events in reproductive behaviors and ovulation are pivotal for the survival of mammalian species. Ovulation in females, which in rats occurs regularly every 4 days, rigidly coincides with the appearance of lordosis behavior that allows males to mount and fertilize females. The central regulation of ovulation and related hormones is mediated through the hypothalamo-pituitary axis, the activity of which is thought to be entrained by the circadian pacemaker located in the suprachiasmatic nucleus (SCN) (1) . Although the pivotal role of SCN efferents in these regulatory mechanisms is evident, less is known about the fine neural circuits by which the suprachiasmatic signals reach the target neuronal elements.
Secretion of anterior pituitary hormones, including gonadotropins and PRL, is regulated by various hypothalamic neurohormones. It is known that the median eminence conveys both humoral and neural signals from the brain to the pituitary. In the external layer of the median eminence, the terminals of hypophysiotropic hormone-producing neurons release their products into the phenestrated portal capillaries that provide the link between the hypothalamus and the anterior pituitary (2) . Neuroendocrine cells are located in various hypothalamic sites, including the medial preoptic area, periventricular areas, and mediobasal hypothalamus as well as in the medial septum and diagonal band of Broca.
Previous morphological studies failed to demonstrate suprachiasmatic efferents in the median eminence or organum vasculosum laminae terminalis (3), indicating that the circadian clock has no direct effect on pituitary hormone secretion, but acts indirectly by regulating the activity of hypophysiotropic hormone-producing neurons. In support of this view, several hypothalamic areas that contain median eminence-projective neurons, such as the medial preoptic area, periventricular areas, and lateral arcuate nucleus, were found to be targets of considerable numbers of SCN efferents (3, 4) . However, it is not known whether those neurons that send projections to portal vessels receive inputs from the SCN.
Several neurotransmitter-and peptide-producing hypothalamic neuronal populations were shown to release their product to the portal vessels of the median eminence. These include dopamine, which is thought to be the mayor hypothalamic regulatory signal in PRL secretion and also partic-ipates in the regulation of other pituitary hormones, including gonadotropins (5) . Evidence has accumulated indicating that the synthesis and/or release of dopamine show diurnal patterns. For example, in rats, the activity of hypothalamic dopamine neurons is circadian, underlying the diurnal secretion pattern of preovulatory PRL secretion (6) . Despite this experimental evidence, our understanding regarding the morphological basis of the circadian secretory function of hyophysiotropic hormones and regulatory peptides is limited.
The objective of the present experiment was to reveal connectivity between the circadian pacemaker and hypothalamic neuroendocrine cells, to demonstrate the relationship between hypothalamic dopamine neurons and suprachiasmatic efferents, and to confirm that SCN efferents have no direct access to fenestrated capillaries. The combination of anterograde and retrograde tracing and light and electron microscopic double and triple immunocytochemistries was used.
Materials and Methods Animals
Ten adult female Sprague-Dawley rats (250 -280 g BW) were kept under standard laboratory conditions (tap water and standard rat chow ad libitum, 12-h light/dark cycle).
Phaseolus vulgaris leucoagglutinin (PHA-L) injections
The projection field of SCN neurons was visualized using PHA-L [2.5% in 10 mm phosphate buffer (PB), pH 7.8; Vector Laboratories, Burlingame, CA] as an anterograde tracer. This was unilaterally applied with iontophoresis via a glass micropipette (tip diameter, 15 m; 5 A positive current applied every other 5 sec for 15 min using a constant current source that is capable of generating up to 2000 V; CS-3 Transcientic System, Canton, MA) into different areas of the SCN [coordinates: anterio-posterior, Ϫ0.8 to Ϫ1.3 mm; lateral, 0.2 mm; ventral, 9.6 mm; according to Paxinos and Watson (7) ].
Fluorogold (FG) injection
Simultaneously with the PHA-L injections, animals received a single ip injection of FG (20 mg/BW; Fluorochrome, Englewood, CO) to label neurons that send projections to regions in the central nervous system that lack the blood-brain barrier (8, 9) .
Fixation
Fifteen days after PHA-L/FG injections, rats were killed under ether anesthesia by transaortic perfusion with 50 ml heparinized saline followed by 250 ml fixative. The fixative consisted of 4% paraformaldehyde, 15% picric acid, and 0.2% glutaraldehyde in 0.1% PB, pH 7.4. The brains were dissected out, and 3-mm thick coronal blocks containing the hypothalamus were postfixed for an additional 1-2 h in glutaraldehydefree fixative.
Tissue preparation and immunostaining
Tissue blocks were rinsed in several changes of PB, and 50-m Vibratome (Lancer) sections were prepared and rinsed four times for 15 min each time in PB. Sections for electron microscopy were transferred into vials containing 0.5 ml 10% sucrose (in PB) and rapidly frozen by immersing the vial in liquid nitrogen to enhance antibody penetration. They were then thawed to room temperature and repeatedly washed in PB. Subsequently, sections for both light and electron microscopy were treated with 1% sodium borohydride in PB for 10 min to eliminate unbound aldehydes from the tissue.
Immunostaining for PHA-L, FG, and tyrosine hydroxylase (TH) was carried out according to the following protocol: incubation in biotinylated rabbit anti-PHA-L (1:250 in PB) containing 1% normal goat serum and 0.3% Triton X-100 for 48 h at 4 C. After several washes in PB, sections were incubated in avidin-biotin-peroxidase (1:500 in PB; ABC Kit, Vector Laboratories, Burlingame, CA), followed by a modified version of the nickel-diaminobenzidene (Ni-DAB) reaction (15 mg DAB, 0.12 mg glucose oxidase, 12 mg ammonium chloride, 600 l 0.05 m nickel ammonium sulfate, and 600 l 10% ␤-d-glucose in 30 ml PB for 5-10 min at room temperature; dark-blue reaction product) to visualize the tissuebound peroxidase. After several rinses in PB, sections were further immunostained for FG. In this procedure, after a 48-h (at 4 C) incubation in rabbit anti-FG antiserum (Biogenesis, Franklin, MA; 1:5000 in PB containing 0.1% sodium azide and 1% normal goat serum), sections were further processed in the secondary antibody (biotinylated goat antirabbit IgG, 1:250 in PB; Vector Laboratories) for 2 h at room temperature, than rinsed in PB three times for 10 min each time and incubated for 2 h at room temperature with ABC Elite (1:250 in PB; ABC Elite Kit, Vector Laboratories), followed by the above-described Ni-DAB reaction. After several rinses in PB, every other section was placed on gelatin-coated slides, dehydrated through increasing ethanol concentrations, and mounted with Permount. The remaining sections were further immunostained for TH. In this procedure, after a 48-h (at 4 C) incubation in mouse anti-TH antiserum (Incstar; 1:1000 in PB containing 0.1% sodium azide and 1% normal horse serum), sections were incubated in the secondary antibody (goat antimouse IgG; 1:50 in PB) for 2 h at room temperature, followed by peroxidase-antiperoxidase:rabbit peroxidaseantiperoxidase (1:100 in PB). Between each incubation step, sections were rinsed three times for 15 min each time in PB. In this case, the tissue-bound peroxidase was visualized by a light brown DAB reaction (15 mg DAB and 165 l 0.3% H 2 O 2 in 30 ml PB for 5-10 min at room temperature; brown reaction product). After immunostaining of the third tissue antigen, sections were thoroughly rinsed in PB, placed on gelatin-coated slides, dehydrated through increasing ethanol concentrations, and mounted with Permount (Fisher Scientific, Fairlawn, NJ). In control experiments, one or two primary antibodies were replaced with normal serum, resulting in single or double immunolabeling.
For electron microscopic analysis, sections were processed the same way as for light microscopy, except the labeling of TH was carried out using 5-nm immunogold-conjugated goat antimouse IgG (Polysciences, Warrington, PA) as secondary antiserum. Subsequently, sections were postosmicated (1% OsO 4 in PB) for 30 min, dehydrated through increasing ethanol concentrations (using 1% uranyl acetate in 70% ethanol for 30 min), flat-embedded in Araldite between liquid release (Electron Microscopy Sciences, Fort Washington, PA)-coated slides and coverslips, and placed in an oven to polymerize for 48 h at 60 C. Flatembedded sections were fixed with a drop of embedding medium on the top of cylindrical araldite blocks and cured again for 48 h at 60 C. Then, blocks were trimmed using light micrographs as a guide in recognizing the selected retrogradely labeled cells and contacts. Ribbons of ultrathin sections (Reichert-Jung Ultramicrotome, Leica Instruments, Deerfield, IL) were collected on Formvar-coated (Electron Microscopy Sciences, Ft. Washington, PA) single slot grids and examined using a Philips CM-10 electron microscope (Rahway, NJ).
Semiquantitative analysis
To gain insight into the extent of colocalization of FG and TH and to approximate the frequency of interconnections between SCN efferents and dopaminergic cells, a semiquantitative analysis was carried out manually on light microscopic material from two animals, using every other section from the beginning of the third ventricle through the hypothalamus up to the anterior part of the mammillary body. When assessing the size of the population of dopaminergic cells that is neuroendocrine, only cell bodies of TH-immunoreactive neurons were analyzed. Putative contacts between dark PHA-L-immunoreactive axon terminals and anything other than cell bodies or proximal dendrites of the light brown TH-immunoreactive and/or FG-labeled neurons were ignored. An axo-somatic or axo-dendritic contact was noted only if a bouton-like structure was in close proximity to a cell body or dendrite and was found as a continuation of its axon by changing the focus plane.
Results
The results of these studies are described in terms of single, double, and triple labeled cells.
Single labeled profiles
PHA-L injection and immunolabeling. Ten animals received PHA-L injections. Histological examination showed that four injections were restricted within the boundaries of the SCN, whereas the rest involved surrounding areas as well. These latter animals were excluded from this study.
All four injections were placed in the SCN (Fig. 1A) . The number of labeled neurons was between 200 -250, representing approximately 2% of the SCN neuron population. Labeled axon terminals were seen in each region of the SCN. The majority of PHA-L-labeled fibers were seen to leave the SCN in the dorsal direction. Few axons were found to run toward and through the contralateral SCN or the ipsilateral optic tract. Sections taken from the diencephalon and adjacent areas showed that anterogradely labeled axons and axon terminals reached ventral aspects of the lateral septum, medial septum, bed nucleus of the stria terminalis medial preoptic area, anteroventral periventricular nucleus, medial preoptic nucleus periventricular region, parvicellular region of the paraventricular nucleus, subparaventricular zone, retrochiasmatic area, anterior hypo-thalamic nucleus, supraoptic decussation, ventrolateral aspects of the ventromedial hypothalamus, the cell-sparse zone between the ventromedial nucleus and the arcuate nucleus, dorsomedial hypothalamic nucleus, and zona incerta. Anterogradely labeled processes were also detected in the optic tract posterior to the injection site, and in the intergeniculate leaflet of the ventrolateral geniculate body. The most abundant network of labeled fibers was detected in the subparaventricular zone, and the least abundant was found in the zona incerta. Although the predominant labeling was observed in the ipsilateral side, some axons were detected in contralateral areas as well.
FG immunolabeling. FG-immunopositive cell bodies and dendrites could be seen throughout the hypothalamus. Retrogradely labeled cells were abundant in the medial septum,
PHA-L-immunoreactive cell bodies are limited to the boundaries of the SCN, and labeled processes can be seen leaving the nucleus dorsally as well as ventrally joining the optic chiasm (OC). B-D, Light micrographs double immunostained for TH and FG. They illustrate the distribution pattern of TH-labeled dopamine cells (light brown profiles) and retrogradely labeled, FG-containing neurons (arrows) within the arcuate nucleus (ARC; B), paraventricular (PVN) and periventricular (Pe) nuclei (C), and zona incerta (ZI; D). Note that the only area where colocalization of TH and FG clearly cannot be seen at this magnification (original magnifications of B and D, ϫ20; C, ϫ10) is the zona incerta (D). In the arcuate nucleus and periventricular areas, the number of TH-immunoreactive neurons that also expressed FG labeling was high. Note the dense TH immunolabeling in axons of the external layer of the median eminence (ME) in B. High power magnification of retrogradely labeled dopamine cells is shown in Fig. 2 . III, Third ventricle. Original magnification of A, ϫ10. medial preoptic area, organum vasculosum of laminae terminalis, diagonal band of Broca, supraoptic and paraventricular nuclei, arcuate nucleus, in the area between the arcuate nucleus and ventrolateral parts of the ventromedial nucleus, and in the zona incerta (see Fig. 1, B-D) . Fewer cells could be seen in the periventricular area, including the subparaventricular zone and retrochiasmatic area, and in the lateral hypothalamus. No labeled neurons were detected in the suprachiasmatic nucleus. The distribution of retrogradely labeled hypothalamic cells corresponded to previous descriptions (8) .
FG immunolabeling resembled that of horseradish peroxidase labeling, whereby the retrogradely transported peroxidase is confined to small cytoplasmic granules (see Figs.  1-3) . Electron microscopic analysis indicated that the FG immunostaining was associated with lysosome-like structures (Fig. 3) .
TH immunostaining.
Immunolabeling for TH resulted in extensive staining throughout the hypothalamus (Fig. 1, B-D) . Labeled cell bodies and dendrites were found in the anteroventral periventricular nucleus, medial preoptic area, periventricular area, parvocellular division of the paraventricular nucleus, anterior hypothalamus, arcuate nucleus, and zona incerta. Axonal processes were abundant in most of the hypothalamic nuclei. The median eminence contained an abundant network of TH-immunoreactive axonal processes in both its internal and external divisions (Fig. 1B) . Immunolabeled processes were also detected in the organum vasculosum of laminae terminalis and subfornical organ. The appearance of TH-containing profiles in this experiment was in accordance with previous reports (10 -13).
Double labeled profiles
FG-TH double labeling. The granular appearance of FG immunoreactivity allowed for the labeling of cytoplasmic TH. In all of the hypothalamic areas in which TH immunoreactivity was detected, retrogradely transported FG was detected in a subpopulation of dopamine (TH) neurons (Figs.  1, B-D, and Fig. 2, D and E) . The highest incidence of double labeled cells was found in the arcuate nucleus (A 12 dopaminergic cell group), where of 2593 TH-immunoreactive cells, 2083 (80%) were also immunolabeled for fluorogold. In the periventricular area (A 12), 1442 TH-immunoreactive cells were analyzed of which 453 (31%) were retrogradely labeled. In the preoptic area (A 14), 42% (349 of 833) of TH-immunoreactive cells were FG immunopositive as well. In the zona incerta, no retrogradely labeled dopamine cells were detected, whereas numerous nearby neurons contained FG (Fig. 1D) . The extent of colocalization of FG and TH in this study corresponds to earlier descriptions of neuroendocrine dopaminergic cells of the hypothalamus (10, 14, 15) .
PHA-L-FG double labeling.
PHA-L immunoreactive dark blue fibers were detected in several regions that contained retrogradely labeled FG-immunoreactive neurons. These regions included the medial septum, medial preoptic area, periventricular areas, the subparaventricular zone just adjacent to the injection site, and a region between the arcuate and ventromedial nuclei. In these regions, PHA-L-labeled SCN efferents could be frequently found in close proximity to FGlabeled cell bodies and proximal dendrites (Fig. 2C) . Although quantitative analysis could not be carried out in this material, the frequency of these connections was highest in the medial septum-diagonal band-medial preoptic area axis and in the cell-sparse zone between the arcuate and ventromedial nuclei. Fewer connections were found in the periventricular area and parvicellular division of the paraventricular nucleus (see Fig. 4 ). The vast majority of the putative connections were observed in the side ipsilateral to the injection, although few connections were seen on the contralateral side. PHA-L-immunoreactive fibers could not be detected in the organum vasculosum laminae terminalis, supraoptic nucleus, magnocellular division of the paraventricular nucleus, and arcuate nucleus, where the highest number of retrogradely labeled neurons was found.
PHA-L-TH double labeling. PHA-L-immunoreactive fibers
were seen in close apposition to TH-immunolabeled cells within the medial preoptic area, anteroventral periventricular area, periventricular and retrochiasmatic regions, and an area between the arcuate nucleus and the ventromedial nucleus (Fig. 2, A and B, and Fig. 3 ). The majority of the appositions occurred between PHA-L-containing axons and the proximal dendrites of TH cells (Fig. 2, A and B) . However, axo-somatic connections could also be detected (Fig. 3) . In this case, again, connections between SCN efferents and dopamine cells were predominantly seen on the side ipsilateral to the injection. However, in a few instances they were also found on the contralateral side.
Triple labeled cells
In the hypothalamic regions (see above), where dopamine cells were detected to be retrogradely labeled, dark blue PHA-L boutons were found in contact with light brown TH-immunoreactive cell bodies and proximal dendrites containing retrogradely transported dark blue FGimmunopositive granules (Fig. 2, D and E) . In a light microscopic semiquantitative analysis it was found that in the arcuate nucleus, where the majority of TH-immunoreactive cells were retrogradely labeled, of 2083 neuroendocrine dopamine cells, 145 (7%) were contacted by PHA-L-immunoreactive, SCN efferents. In the periventricular area, 5% (27 of 453) of the neuroendocrine and 10% (93 of 998) of the nonneuroendocrine dopamine cells were targeted by SCN efferents. In the preoptic area, PHA-L-immunoreactive axon terminals were in close proximity to 6% (21 of 349) of the neuroendocrine and 7% (34 of 484) of the nonneuroendocrine dopamine cells.
Electron microscopic analysis of this material revealed synaptic connections between PHA-L-immunoreactive axon terminals and retrogradely labeled TH cells (Fig. 3) . The synaptic membrane specializations seemed to be symmetrical (Fig. 3) .
Discussion Methodology
Simultaneous application of the anterograde tracer PHA-L and systemic administration of the retrograde tracer FG al- lowed demonstration of SCN inputs of neurons with direct access to blood vessels. The advantage of using FG instead of horseradish peroxidase (HRP), which labels neurons similarly to FG, is that FG can remain within neurons for months (8, 9) , whereas HRP is eliminated within a few days. The HRP-like appearance of FG enabled the use of the same chromogen (Ni-DAB) for PHA-L-and FG-immunoreactive profiles. As the granular FG immunoreactivity was localized to lysosome-like organelles only, it was possible to further immunolabel these cells for TH, the antigen that is located homogeneously in the cytoplasm. The use of dark Ni-DAB and light brown DAB reactions made it simple to distinguish among the three tissue antigens.
Intraperitoneal administration of FG results in retrograde labeling in neural cells that project to areas that lack a bloodbrain barrier (8) . These areas in the central nervous system include the so-called circumventricular organs, i.e. the organum vasculosum laminae terminalis, subfornical organ, median eminence, and area postrema (16) . In addition, the pineal gland and the posterior pituitary lack the blood-brain barrier (16) . Therefore, the interpretation of the present observations without the results of previous anatomical studies delineating the contributions of various hypothalamic nuclei to the innervation of the aforementioned circumventricular organs, cannot be complete. For example, it is known that neurons in the medial septum-diagonal band-medial preoptic area region send projections to the organum vasculosum laminae terminalis, subfornical organ, and median eminence (for review, see Ref. 16 ). On the other hand, the region of the mediobasal hypothalamus is considered to project predominantly to the median eminence and not to the other circumventricular organs (16) .
SCN efferents to neuroendocrine-and/or TH-containing neurons
The present results show that a large number of hypothalamic sites are innervated by the SCN and, therefore, are potentially the terminal field for relaying circadian messages. Detailed description of the anterogradely labeled SCN efferents was not in the scope of this report; however, it can be concluded that the present results are in absolute agreement with the elaborated studies of Watts et al. (3, 4) . It should be noted that the PHA-L injections were placed in the ventral aspects of the SCN, and only about 2% of SCN perikarya were labeled. Therefore, it could not be ruled out that other SCN cells may send processes to the median eminence. However, the lack of FG labeling in cells of the SCN after peripheral injection of this retrograde tracer indicates that neurons in this area do not have direct access to vessels lacking the blood-brain barrier. In light of the estimation that approximately 2% of SCN efferents were labeled in these experiments, the semiquantitative analysis of the connectivity between SCN efferents and neuroendocrine/nonneuroendocrine dopamine cells has to be interpreted with caution. In vivo, a higher incidence of interaction is expected.
In most of the hypothalamic nuclei where FG was observed, anterogradely labeled SCN efferents were found to be in close apposition to FG-immunopositive cell bodies and dendrites (Fig. 5) . Previous pharmacological and morphological experiments demonstrated that hypothalamic neural systems that have a direct access to the portal vessels and, therefore, can be retrogradely labeled by peripheral FG injection contain a variety of neuropeptides and neurotransmitters (for review, see Ref. 17) , including LHRH (18, 19) , CRF (20) , GH-releasing hor- mone (21), TRH (22) , somatostatin (23) , dopamine (24) , serotonin (25, 26) , galanin (9) , and ␥-aminobutyric acid (27, 28) . Our present observations of SCN efferents on neuroendocrine cells suggests that at least some of these systems may be directly regulated by the SCN. In accordance, recent studies indicated that LHRH neurons are indeed targets of axon terminals originating in the SCN (29 -31) .
The triple immunolabeling experiments of the present study revealed that SCN-target, retrogradely labeled cells in different hypothalamic sites express TH immunoreactivity. TH-immunoreactive cell bodies in the hypothalamus represent exclusively dopaminergic neurons, as immunostaining for the enzymes responsible for norepinephrine or epinephrine synthesis failed to reveal immunoreactive perikarya in the hypothalamus (10, 32, 33) . Therefore, the present results provide a morphological basis for the information flow between the SCN and dopamine cells (Fig. 5) . A population of these dopaminergic neurons was retrogradely labeled, indicating that they contact portal capillaries in either the external layer of the median eminence or the portal capillaries of the posterior and intermediate lobes of the pituitary. In either case, dopamine released into portal vessels can influence lactotrophs in the anterior pituitary as well as the release of other hypophysyotropic hormones, such as LHRH. On the other hand, dopamine neurons that lacked retrogradely transported FG were also found to be targets of SCN efferents. These cells are known to innervate a wide variety of regions in the central nervous system (10, 11) . For example, most of the hypophysiotropic hormone-producing neural systems, including LHRH (34) , are targets of a considerable number of TH-containing axon terminals. Thus, the current findings suggest that SCN signals may reach hypophysiotropic hormone-producing neural systems indirectly as well, via dopamine interneurons.
Functional implications
The present results provide a morphological basis for the information flow between the circadian pacemaker suprachiasmatic nucleus and neuroendocrine neurons (Fig. 5) . The majority of SCN-target retrogradely labeled neurons were found in the medial preoptic area, periventricular area, and lateral aspects of the arcuate nucleus. The vast majority of these neurons send their projections to the median eminence, whereas a portion of cells in the medial preoptic area may have been labeled from the organum vasculosum laminae terminalis (8) . Although there is a paucity of information on the function of the organum vasculosum laminae terminalis, the role of the median eminence and its portal vessel system in the regulation of anterior pituitary functions is well established (2) .
Neurons with direct access to portal veins contain different neurotransmitters and modulators as well as specific trophic and static hormones that are released from the nerve terminals to the portal capillaries, reach the anterior pituitary, and alter the production and secretion of pituitary hormones. The secretion of most of the anterior pituitary hormones, including gonadotropins and PRL, shows diurnal variations (35) (36) (37) (38) (39) (40) (41) (42) (43) . Under normal physiological conditions, the entrainment of these rhythms is by the light-dark cycle (41) . The light-dark cycle influences the neuroendocrine hypothalamus at least in part through direct retinal projections to the SCN (41, 44) .
PRL secretion. The production and secretion of PRL show diurnal patterns and are under the control of the mediobasal hypothalamus. Dopamine secreted into the portal capillaries is considered to be the major regulatory substance in PRL production and release (5, 45) . On the day of proestrus, and every day in estrogen-primed ovariectomized rats, PRL secretion from the anterior pituitary is increased in the afternoon (46) . This elevation of PRL is at least in part due to decreased dopamine release induced by the preovulatory estrogen surge (47) . It was demonstrated that in ovariectomized, estrogen-primed rats, significant decreases in median eminence dihydroxyphenylacetic acid and dehydroxyphenylalanine occur in parallel with the increased PRL secretion (6) . The nature of these events is circadian (48) , and destruction of the suprachiasmatic nucleus abolishes the development of afternoon PRL surges (6, 49) . The present study demonstrating a direct connection between the SCN and neuroendocrine dopamine cells offers a neural pathway by which circadian signals alter PRL secretion.
Gonadotropin secretion. Circadian activity is also characteristic for both the daily release and the preovulatory release of gonadotropins (41) . It is suggested that the release from the inhibitory tone on LHRH neurons initiates both the afternoon and preovulatory gonadotropin surges. As a population of dopamine neurons in the periventricular areas was shown to project to the preoptic area and terminate on LHRH neurons (34) , the innervation of nonretrogradely labeled TH cells in the same regions by SCN efferents raises the possibility that suprachiasmatic signals may reach LHRH cell bodies via these catecholamine neurons. On the other hand, neuroendocrine dopamine cells, too, may convey circadian signals to LHRH cells at the level of the median eminence. It is reasonable to postulate that as the SCN efferents are probably inhibitory in nature (vasoactive intestinal polypeptide and ␥-aminobutyric acid content) (50, 51) , the activation of SCN neurons may inhibit the dopamine neuronal network, resulting in a disinhibition of LHRH neurons at the level of either the cell bodies (preoptic area) or the axon terminals (median eminence).
Conclusions
This study using anterograde and retrograde tracing techniques in combination with immunocytochemistry, provided evidence that 1) the circadian pacemaker suprachiasmatic nucleus sends direct efferents onto neuroendocrine cells of different hypothalamic nuclei; 2) a subpopulation of SCN target neuroendocrine cells contains dopamine; and 3) suprachiasmatic efferents do not reach fenestrated capillaries. These observations suggest that the circadian pacemaker has no direct effect on the regulation of anterior pituitary functions, but indicate a pathway by which circadian signals are integrated into the hypothalamo-pituitary-gonadal axis. It needs to be explored whether the integration of hormonal and circadian signals, a mandatory process in the regulation of the anterior pituitary, which was indicated to occur in populations of hypothalamic neurons (52) , may be the same cells that were found to be neuroendocrine in the present study.
